CervoMed Inc. Interest Expense
CervoMed Inc. (CRVO) reported Interest Expense of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-03-29
- CervoMed Inc. interest expense for the quarter ending 2017-06-30 was $18.89K, a 203.88% increase year-over-year.
- CervoMed Inc. interest expense for the quarter ending 2017-03-31 was $55.72K, a 265228.57% increase year-over-year.
- CervoMed Inc. interest expense for the quarter ending 2016-12-31 was $36.15K, a 76.34% decline year-over-year.
- CervoMed Inc. interest expense for the quarter ending 2016-09-30 was $1.38K, a 98.19% decline year-over-year.
- CervoMed Inc. interest expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CervoMed Inc. interest expense for fiscal 2022 was $587.00.
- CervoMed Inc. interest expense for fiscal 2018 was $3.00K, a 97.00% decline from fiscal 2017.
- CervoMed Inc. interest expense for fiscal 2017 was $100.00K, a 170.27% increase from fiscal 2016.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-29 | ||||||
| 2022-12-31 | $587.00 10-K · filed 2024-03-29 | ||||||
| 2018-12-31 | $3.00K 10-K · filed 2019-03-19 | ||||||
| 2017-12-31 | $100.00K 10-K · filed 2019-03-19 | ||||||
| 2017-06-30 | $18.89K 10-Q · filed 2017-08-14 | $74.61K 10-Q · filed 2017-08-14 | $110.75K derived: sum of 3 quarters · filed 2018-04-02 | $112.13K derived: sum of 4 quarters · filed 2018-04-02 | |||
| 2017-03-31 | $55.72K 10-Q · filed 2017-05-15 | $91.86K derived: sum of 2 quarters · filed 2018-04-02 | $93.24K derived: sum of 3 quarters · filed 2018-04-02 | $99.46K derived: sum of 4 quarters · filed 2018-04-02 | |||
| 2016-12-31 | $36.15K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $37.52K derived: sum of 2 quarters · filed 2018-04-02 | $43.74K derived: sum of 3 quarters · filed 2018-04-02 | $37.00K 10-K · filed 2018-04-02 | $29.69K 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $1.38K 10-Q · filed 2016-11-14 | $7.59K derived: sum of 2 quarters · filed 2017-08-14 | $854.00 10-Q · filed 2016-11-14 | $160.42K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-06-30 | $6.22K 10-Q · filed 2017-08-14 | $6.24K 10-Q · filed 2017-08-14 | $159.04K derived: sum of 3 quarters · filed 2017-08-14 | $235.21K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $21.00 10-Q · filed 2017-05-15 | $152.82K derived: sum of 2 quarters · filed 2017-05-15 | $228.99K derived: sum of 3 quarters · filed 2017-05-15 | $262.33K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $152.80K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $228.97K derived: sum of 2 quarters · filed 2017-03-31 | $262.31K derived: sum of 3 quarters · filed 2017-03-31 | $313.12K 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $76.17K 10-Q · filed 2016-11-14 | $109.51K derived: sum of 2 quarters · filed 2016-11-14 | $160.31K 10-Q · filed 2016-11-14 | $152.27K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $33.34K 10-Q · filed 2016-08-15 | $84.15K 10-Q · filed 2016-08-15 | $76.10K derived: sum of 3 quarters · filed 2016-08-15 | $162.77K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $50.81K 10-Q · filed 2016-05-16 | $42.77K derived: sum of 2 quarters · filed 2016-05-16 | $129.44K derived: sum of 3 quarters · filed 2016-05-16 | $266.02K derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$8.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $78.63K derived: sum of 2 quarters · filed 2016-03-25 | $215.21K derived: sum of 3 quarters · filed 2016-03-25 | $273.50K 10-K · filed 2016-03-25 | |||
| 2014-09-30 | $86.67K 10-Q · filed 2015-11-12 | $223.25K derived: sum of 2 quarters · filed 2015-11-12 | $281.55K 10-Q · filed 2015-11-12 | $336.61K derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-06-30 | $136.58K 10-Q · filed 2015-08-12 | $194.88K 10-Q · filed 2015-08-12 | $249.94K derived: sum of 3 quarters · filed 2015-08-12 | $263.30K derived: sum of 4 quarters · filed 2015-08-12 | |||
| 2014-03-31 | $58.29K 10-Q · filed 2015-05-11 | -$58.29K 10-Q · filed 2014-05-20 | $113.36K derived: sum of 2 quarters · filed 2015-05-11 | $126.72K derived: sum of 3 quarters · filed 2015-05-11 | $161.80K derived: sum of 4 quarters · filed 2015-05-11 | ||
| 2013-12-31 | $55.06K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $68.43K derived: sum of 2 quarters · filed 2015-04-03 | $103.51K derived: sum of 3 quarters · filed 2015-04-03 | $126.48K 10-K · filed 2015-04-03 | -$228.29K 10-K/A · filed 2014-04-23 | ||
| 2013-09-30 | $13.37K 10-Q · filed 2014-11-12 | -$35.20K 10-Q · filed 2013-11-19 | $48.45K derived: sum of 2 quarters · filed 2014-11-12 | $71.42K 10-Q · filed 2014-11-12 | -$152.79K 10-Q · filed 2013-11-19 | -$37.98K derived: sum of 4 quarters · filed 2014-11-12 | |
| 2013-06-30 | $35.08K 10-Q · filed 2014-08-14 | $58.05K 10-Q · filed 2014-08-14 | -$51.35K derived: sum of 3 quarters · filed 2014-08-14 | -$51.35K derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | -$22.97K 10-Q · filed 2014-05-20 | -$86.43K derived: sum of 2 quarters · filed 2014-05-20 | -$86.43K derived: sum of 3 quarters · filed 2014-05-20 | -$138.75K derived: sum of 4 quarters · filed 2014-05-20 | |||
| 2012-12-31 | -$63.46K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | -$63.46K derived: sum of 2 quarters · filed 2014-04-23 | -$115.78K derived: sum of 3 quarters · filed 2014-04-23 | -$167.89K 10-K/A · filed 2014-04-23 | $167.89K 10-K/A · filed 2013-04-24 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-19 | -$52.31K derived: sum of 2 quarters · filed 2013-11-19 | -$104.43K 10-Q · filed 2013-11-19 | $0.00 10-Q · filed 2012-11-19 | |||
| 2012-06-30 | -$52.31K 10-Q · filed 2013-11-19 | ||||||
| 2011-12-31 | $18.11K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $18.11K derived: sum of 2 quarters · filed 2013-04-24 | $30.54K 10-K/A · filed 2013-04-24 | ||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-19 | $12.42K 10-Q · filed 2012-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |